Clinical trial

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

NCT00547339

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2006-07-01Date precision: month

Registry last updated2022-12-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

stereotactic body radiation therapy (SBRT)- 45 GyRADIATION

stereotactic body radiation therapy (SBRT) - 47.5 GyRADIATION

stereotactic body radiation therapy (SBRT) - 50 Gy (Phase 1)RADIATION

stereotactic body radiation therapy (SBRT) - 50 Gy (Phase 2)RADIATION

Sponsors & collaborators

University of Texas Southwestern Medical Centerlead sponsor

Mapped research locations

DallasTexas, United States1 MinneapolisMinnesota, United States1 OrlandoFlorida, United States1 AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00547339 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.